Ally Bridge Group

Ally Bridge Group as of June 30, 2023

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 17 positions in its portfolio as reported in the June 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Reata Pharmaceuticals Inc-a Cl A 13.0 $11M 106k 101.96
Verona Pharma Plc - Sponsored Ads (VRNA) 12.5 $10M 488k 21.14
Xenon Pharmaceuticals (XENE) 12.4 $10M 267k 38.50
Cytokinetics Com New (CYTK) 8.8 $7.3M 223k 32.62
Geron Corporation (GERN) 8.3 $6.8M 2.1M 3.21
Merus N V (MRUS) 6.4 $5.2M 199k 26.33
Miragen Therapeutics (VRDN) 5.8 $4.8M 202k 23.79
Moonlake Immunotherapeutics Class A Ord (MLTX) 5.6 $4.7M 91k 51.00
Marinus Pharmaceuticals Com New (MRNS) 5.1 $4.2M 390k 10.86
Black Diamond Therapeutics (BDTX) 4.9 $4.0M 800k 5.05
Praxis Precision Medicines I 4.5 $3.7M 3.2M 1.15
Jasper Therapeutics 4.2 $3.4M 2.5M 1.37
Compass Therapeutics (CMPX) 3.5 $2.9M 915k 3.18
Medavail Holdings Ord 1.8 $1.4M 5.9M 0.25
Mdxhealth Sa- Sponsored Ads 1.4 $1.2M 350k 3.41
Context Therapeutics (CNTX) 1.3 $1.0M 653k 1.60
Rapid Micro Biosystems Inc-a Class A Com (RPID) 0.5 $403k 403k 1.00